Skip to main content

Advertisement

SpringerLink
Log in

A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Curcumin, a lipophilic polyphenol derived from the rhizome of the plant turmeric (Curcuma longa), might be useful in the prevention and treatment of a number of degenerative brain disorders, including glioma multiforma and Alzheimer’s disease. Thus, there is growing interest in measuring curcumin concentrations in the brain and other target tissues in relevant animal models. We therefore developed and validated (according to the Food and Drug Administration guidelines for bioanalytical method validation), a simple, fast and reliable method for the quantification of curcumin in biological matrices by fast high-performance liquid chromatography with fluorescence detection. This method involves a simple extraction with 95% ethyl acetate and 5% methanol, rapid separation (<2 min if external standards and <4 min if the internal standard β-estradiol 17-acetate is used) on a Jasco Reprosil-Pur Basic C18 column (75 × 2 mm, 1.8 μm) with an eluent of acetonitrile, methanol, de-ionised water and acetic acid (49:20:30:1, v/v; flow rate, 0.4 mL/min) and fluorescence detection (excitation wavelength, 420 nm; emission wavelength, 470 nm). The method is selective, precise (<15% RSD at the lower limit of quantification), accurate (<15% of the coefficient of variation at the lower limit of quantification) and sensitive over a linear range of 0.05–10 μg/mL for curcumin. The developed method was used for the quantification of curcumin in the brains of mice force-fed (50 mg/kg bw) or i.p. injected (100 mg/kg bw) with curcumin. Brain curcumin concentrations of the mice were below the limit of detection at 30, 60 and 120 min after oral gavage and reached 4–5 μg/g brain 20–40 min after i.p. injection. In conclusion, the developed and validated method should be useful for the accurate and precise quantification of curcumin in target organs from relevant animal models of human diseases.

Representative chromatograms of curcumin extracted from brains of mice that were intraperitoneally injected with curcumin (100 mg/kg bw). Brains were removed 20, 30 or 40 min (red, blue, and green trace, respectively) after injection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Strimpakos AS, Sharma RA (2008) Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10:511–545

    Article  CAS  Google Scholar 

  2. Bengmark S (2006) Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. J Parenter Enteral Nutr 30:45–51

    Article  CAS  Google Scholar 

  3. Bengmark S, Mesa MD, Gil A (2009) Plant-derived health: the effects of turmeric and curcuminoids. Nutricion hospitalaria: organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral 24:273–281

    CAS  Google Scholar 

  4. Nguyen DT, Guillarme D, Rudaz S, Veuthey JL (2006) Fast analysis in liquid chromatography using small particle size and high pressure. J Sep Sci 29:1836–1848

    Article  CAS  Google Scholar 

  5. Heath DD, Pruitt MA, Brenner DE, Rock CL (2003) Curcumin in plasma and urine: quantitation by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 783:287–295

    Article  CAS  Google Scholar 

  6. Food and Drug Administration (2001) Guidance for industry—bioanalytical method validation. Food and Drug Administration, Rockville, p 25

    Google Scholar 

  7. Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, Brenner DE (2008) Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomark Prev 17:1411–1417

    Article  CAS  Google Scholar 

  8. Tønnesen HH, Karlsen J (1983) High-performance liquid chromatography of curcumin and related compounds. J Chromatogr 259:367–371

    Article  Google Scholar 

  9. Zhang J, Jinnai S, Ikeda R, Wada M, Hayashida S, Nakashima K (2009) A simple HPLC-fluorescence method for quantitation of curcuminoids and its application to turmeric products. Anal Sci 25:385–388

    Article  Google Scholar 

  10. Magee JA, Herd AC (1999) Internal standard calculations in chromatography. J Chem Educ 76:252

    Article  CAS  Google Scholar 

  11. Pan MH, Huang TM, Lin JK (1999) Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486–494

    CAS  Google Scholar 

  12. Purkayastha S, Berliner A, Fernando SS, Ranasinghe B, Ray I, Tariq H, Banerjee P (2009) Curcumin blocks brain tumor formation. Brain Res 1266:130–138

    Article  CAS  Google Scholar 

  13. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, Farmer PB, Steward WP, Gescher AJ (2002) Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomark Prev 11:105–111

    CAS  Google Scholar 

  14. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818

    Article  CAS  Google Scholar 

  15. Bisht S, Maitra A (2009) Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr Drug Discov Technol 6:192–9

    Article  CAS  Google Scholar 

  16. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37:223–230

    Article  CAS  Google Scholar 

  17. Usta M, Wortelboer HM, Vervoort J, Boersma MG, Rietjens IM, van Bladeren PJ, Cnubben NH (2007) Human glutathione S-transferase-mediated glutathione conjugation of curcumin and efflux of these conjugates in Caco-2 cells. Chem Res Toxicol 20:1895–1902

    Article  CAS  Google Scholar 

  18. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP (2004) Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10:6847–6854

    Article  CAS  Google Scholar 

  19. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895–2900

    CAS  Google Scholar 

  20. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP (2001) Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7:1894–1900

    CAS  Google Scholar 

  21. Lao CD, MTt R, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10

    Article  Google Scholar 

  22. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892–5901

    Article  CAS  Google Scholar 

Download references

Acknowledgement

GR acknowledges the financial support by the DFG Cluster of Excellence “Inflammation at Interfaces”.

Author information

Author notes

  1. Christina Schiborr & Jan Frank

    Present address: Institute of Biological Chemistry and Nutrition, University of Hohenheim, Garbenstr 28, 70599, Stuttgart, Germany

Authors and Affiliations

  1. Institute of Human Nutrition and Food Science, Christian-Albrechts-University, 24118, Kiel, Germany

    Christina Schiborr, Gerald Rimbach & Jan Frank

  2. Department of Pharmacology, Biocenter Niederursel, University of Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany

    Gunter P. Eckert

Authors
  1. Christina Schiborr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunter P. Eckert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerald Rimbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Frank.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schiborr, C., Eckert, G.P., Rimbach, G. et al. A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection. Anal Bioanal Chem 397, 1917–1925 (2010). https://doi.org/10.1007/s00216-010-3719-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-010-3719-3

Keywords

Search

Navigation